Catalyst Wire Dossier Catalyst Wire Dossier

Newcastle disease virus-vectored SARS-CoV-2 vaccine

live recombinant Newcastle disease virus-vectored SARS-CoV-2 vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Newcastle disease virus-vectored SARS-CoV-2 vaccine, covering 2025-04-17 to 2025-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. [Phase 1]

See pricing